A.P. Pharma, Inc. · Redwood City, CA United States (NASDAQ: APPA)
| 123 Saginaw Dr. | Phone: 650-366-2626 |
| Redwood City, CA | Fax: 650-365-6490 |
| 94063 | |
| United States | 
Map This Company |
A.P. Pharma, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
A.P. Pharma wants to hit you where it hurts. The firm develops bioerodible polymers for injectable and implantable drug delivery. Its Biochronomer technology delivers medication directly to the site where the drug is needed. A.P. Pharma's leading drug candidate, APF530, could ease chemotherapy-induced nausea and vomiting. A second candidate in clinical trials is a post-surgical pain management product that delivers pain relief right to the surgical site. A.P. Pharma is also developing therapies for inflammation and chronic pain using its Biochronomer technology. Its drug candidates combine approved therapeutics with its bioerodible polymers.
A.P. Pharma, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: APPA Single Location |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 18 |
Executives
13 executives listed for A.P. Pharma, Inc.'s Redwood City, CA location.
| Chairman | Paul Goddard | |
|---|---|---|
| Acting CEO | John Whelan | |
| SVP Research and Development | John Barr |